Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3–IR and GM1–TrkA interactions

The interactions between gangliosides and proteins belonging to the same or different lipid domains and their influence on physiological and pathological states have been analysed in detail. A well‐known factor impacting on lipid–protein interactions and their biological outcomes is the dynamic composition of plasma membrane. This review focuses on GM1 and GM3 gangliosides because they are an integral part of protein–receptor complexes and dysregulation of their concentration shows a direct correlation with the onset of pathological conditions. We first discuss the interaction between GM3 and insulin receptor in relation to insulin responses, with an increase in GM3 correlating with the onset of metabolic dysfunction. Next, we describe the case of the GM1–TrkA interaction, relevant to nerve‐cell differentiation and homeostasis as deficiency in plasma‐membrane GM1 is known to promote neurodegeneration. These two examples highlight the fact that interactions between gangliosides and receptor proteins within the plasma membrane are crucial in controlling cell signalling and pathophysiological cellular states.

[1]  R. Mendez-Otero,et al.  Gangliosides in nervous system development, regeneration, and pathologies , 2022, Neural regeneration research.

[2]  K. Iwabuchi,et al.  Lactosylceramide-enriched microdomains mediate human neutrophil immunological functions via carbohydrate-carbohydrate interaction , 2022, Glycoconjugate Journal.

[3]  J. Laman,et al.  Guillain-Barré syndrome: expanding the concept of molecular mimicry. , 2022, Trends in immunology.

[4]  E. Chiricozzi,et al.  Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition , 2022, Biomedicines.

[5]  R. Ledeen,et al.  The Key Role of GM1 Ganglioside in Parkinson’s Disease , 2022, Biomolecules.

[6]  R. Ledeen,et al.  Systemic deficiency of GM1 ganglioside in Parkinson’s disease tissues and its relation to the disease etiology , 2022, Glycoconjugate journal.

[7]  J. Fantini,et al.  Ganglioside binding domains in proteins: Physiological and pathological mechanisms. , 2022, Advances in protein chemistry and structural biology.

[8]  C. Tifft,et al.  GM1 Gangliosidosis—A Mini-Review , 2021, Frontiers in Genetics.

[9]  K. Fukase,et al.  Homeostatic and pathogenic roles of the GM3 ganglioside , 2021, The FEBS journal.

[10]  E. Chiricozzi,et al.  The structure of gangliosides hides a code for determining neuronal functions , 2021, FEBS open bio.

[11]  E. Chiricozzi,et al.  Turning the spotlight on the oligosaccharide chain of GM1 ganglioside , 2021, Glycoconjugate journal.

[12]  E. Chiricozzi,et al.  Glycosphingolipids. , 2021, Advances in experimental medicine and biology.

[13]  E. Chiricozzi,et al.  Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells , 2020, Glycoconjugate Journal.

[14]  S. Sipione,et al.  Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications , 2020, Frontiers in Neuroscience.

[15]  Radek Šachl,et al.  Organization of gangliosides into membrane nanodomains , 2020, FEBS letters.

[16]  G. Lippi,et al.  GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease , 2020, International journal of molecular sciences.

[17]  N. Mitro,et al.  The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells , 2020, Glycoconjugate Journal.

[18]  E. Chiricozzi,et al.  GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration , 2020, International journal of molecular sciences.

[19]  V. Manganelli,et al.  A multimolecular signaling complex including PrPC and LRP1 is strictly dependent on lipid rafts and is essential for the function of tissue plasminogen activator , 2020, Journal of neurochemistry.

[20]  P. Magistretti,et al.  Gangliosides: Treatment Avenues in Neurodegenerative Disease , 2019, Front. Neurol..

[21]  M. Maggioni,et al.  GM1 promotes TrkA‐mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkA , 2019, Journal of neurochemistry.

[22]  M. Maggioni,et al.  The Neuroprotective Role of the GM1 Oligosaccharide, II3Neu5Ac-Gg4, in Neuroblastoma Cells , 2019, Molecular Neurobiology.

[23]  R. Schnaar.  The Biology of Gangliosides. , 2019, Advances in carbohydrate chemistry and biochemistry.

[24]  J. Schneider.  Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson’s disease , 2018, PloS one.

[25]  A. Menon,et al.  Transbilayer lipid asymmetry , 2018, Current Biology.

[26]  P. Hadaczek,et al.  Ganglioside Metabolism and Parkinson's Disease , 2018, Front. Neurosci..

[27]  Keiichiro Sakuma,et al.  Gangliosides and Tumors. , 2018, Methods in molecular biology.

[28]  L. Cantu',et al.  Building a biomimetic membrane for neutron reflectivity investigation: Complexity, asymmetry and contrast. , 2017, Biophysical Chemistry.

[29]  M. Maggioni,et al.  Role of the GM1 ganglioside oligosaccharide portion in the TrkA‐dependent neurite sprouting in neuroblastoma cells , 2017, Journal of neurochemistry.

[30]  C. Gelfi,et al.  NEU3 Sialidase Protein Interactors in the Plasma Membrane and in the Endosomes* , 2016, The Journal of Biological Chemistry.

[31]  C. Schengrund,et al.  Gangliosides: glycosphingolipids essential for normal neural development and function. , 2015, Trends in biochemical sciences.

[32]  R. Ledeen,et al.  The multi-tasked life of GM1 ganglioside, a true factotum of nature. , 2015, Trends in biochemical sciences.

[33]  A. Davidow,et al.  GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model , 2015, Experimental Neurology.

[34]  T. Adachi,et al.  Neurotropin promotes NGF signaling through interaction of GM1 ganglioside with Trk neurotrophin receptor in PC12 cells , 2015, Brain Research.

[35]  M. Masserini,et al.  Role of Lipid Rafts and GM1 in the Segregation and Processing of Prion Protein , 2014, PloS one.

[36]  Rita Gerardy-Schahn,et al.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. , 2014, Physiological reviews.

[37]  N. Loberto,et al.  Plasma Membrane-Associated Glycohydrolases Activation by Extracellular Acidification due to Proton Exchangers , 2012, Neurochemical Research.

[38]  Kai Simons,et al.  Membrane organization and lipid rafts. , 2011, Cold Spring Harbor perspectives in biology.

[39]  J. Inokuchi.  Membrane microdomains and insulin resistance , 2010, FEBS letters.

[40]  Takako Sasaki,et al.  Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth , 2009, Journal of Cell Science.

[41]  A. Duchemin,et al.  GM1‐induced activation of phosphatidylinositol 3‐kinase: involvement of Trk receptors , 2008, Journal of neurochemistry.

[42]  Y. Igarashi,et al.  Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[43]  S. Hakomori,et al.  Interaction of N-linked glycans, having multivalent GlcNAc termini, with GM3 ganglioside , 2006, Glycoconjugate Journal.

[44]  A. Duchemin,et al.  GM1 and ERK signaling in the aged brain , 2005, Brain Research.

[45]  H. Koga,et al.  Stable Transfection of GM1 Synthase Gene into GM1-Deficient NG108-15 Cells, CR-72 Cells, Rescues the Responsiveness of TRK-Neurotrophin Receptor to Its Ligand, NGF , 2002, Neurochemical Research.

[46]  S. Sonnino,et al.  A procedure for the preparation of GM3 ganglioside from GM1-lactone , 1999, Glycoconjugate Journal.

[47]  M A Chester,et al.  IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) Nomenclature of glycolipids: Recommendations 1997 , 2004, Glycoconjugate Journal.

[48]  N. Loberto,et al.  The adhesion protein TAG‐1 has a ganglioside environment in the sphingolipid‐enriched membrane domains of neuronal cells in culture , 2003, Journal of neurochemistry.

[49]  R. Proia,et al.  Enhanced insulin sensitivity in mice lacking ganglioside GM3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Duchemin,et al.  GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain , 2002, Journal of neurochemistry.

[51]  H. Simon,et al.  Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides* , 2002, The Journal of Biological Chemistry.

[52]  Y. Igarashi,et al.  Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance* , 2002, The Journal of Biological Chemistry.

[53]  Deborah A. Brown,et al.  Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts* , 2000, The Journal of Biological Chemistry.

[54]  M. Masserini,et al.  Tubulin Anchoring to Glycolipid-enriched, Detergent-resistant Domains of the Neuronal Plasma Membrane* , 2000, The Journal of Biological Chemistry.

[55]  K. Iwabuchi,et al.  Separation of glycosphingolipid-enriched microdomains from caveolar membrane characterized by presence of caveolin. , 2000, Methods in enzymology.

[56]  K. Iwabuchi,et al.  Separation of “Glycosphingolipid Signaling Domain” from Caveolin-containing Membrane Fraction in Mouse Melanoma B16 Cells and Its Role in Cell Adhesion Coupled with Signaling* , 1998, The Journal of Biological Chemistry.

[57]  S. Sonnino,et al.  Conformation of the oligosaccharide chain of G(M1) ganglioside in a carbohydrate-enriched surface. , 1998, Biophysical journal.

[58]  R. G. Anderson.  The caveolae membrane system. , 1998, Annual review of biochemistry.

[59]  M. Masserini,et al.  A photo‐reactive derivative of ganglioside GM1 specifically cross‐links VIP21‐caveolin on the cell surface , 1995, FEBS letters.

[60]  M. Hamaguchi,et al.  Ganglioside GM1 binds to the Trk protein and regulates receptor function. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Gottfries,et al.  Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) , 1994, Journal of neurochemistry.

[62]  S. Hakomori,et al.  GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. , 1994, The Journal of biological chemistry.

[63]  S. Hakomori,et al.  A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity. Possible association of ganglioside-induced inhibition of insulin receptor function and monocytic differentiation induction in HL-60 cells. , 1991, The Journal of biological chemistry.

[64]  J. Månsson,et al.  Human brain gangliosides: developmental changes from early fetal stage to advanced age. , 1989, Biochimica et biophysica acta.

[65]  Portland Press Ltd.  IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983 , 1984 .

[66]  A. Gorio,et al.  Gangliosides enhance neurite outgrowth in PC12 cells. , 1983, Brain research.

[67]  J. Sclafani,et al.  Ganglioside‐Induced Neuritogenesis: Verification That Gangliosides Are the Active Agents, and Comparison of Molecular Species , 1983, Journal of neurochemistry.

[68]  M. Seashore.  Structure and Function of Gangliosides , 1980, Advances in experimental medicine and biology.